206 related articles for article (PubMed ID: 4080755)
1. The effect of dopamine receptor agonist treatment on haloperidol-induced supersensitivity in mice.
Fayle P; Jackson DM; Jenkins OF; Lafferty PA
Pharmacol Biochem Behav; 1985 Nov; 23(5):715-20. PubMed ID: 4080755
[TBL] [Abstract][Full Text] [Related]
2. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.
Pittman KJ; Jakubovic A; Fibiger HC
Psychopharmacology (Berl); 1984; 82(4):371-7. PubMed ID: 6427831
[TBL] [Abstract][Full Text] [Related]
3. Bromocriptine potentiates the behavioural effects of directly and indirectly acting dopamine receptor agonists in mice.
Jenkins OF; Jackson DM
Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct; 331(1):7-11. PubMed ID: 3877878
[TBL] [Abstract][Full Text] [Related]
4. The effect of chronic bromocriptine and L-dopa on spiperone binding and apomorphine-induced stereotypy.
Globus M; Bannet J; Lerer B; Belmaker RH
Psychopharmacology (Berl); 1982; 78(1):81-4. PubMed ID: 6815701
[TBL] [Abstract][Full Text] [Related]
5. Effect of aliphatic monoamines on motor activity of mice: no direct interaction with dopaminergic D2 receptor.
Widy-Tyszkiewicz E; Członkowski A
Pol J Pharmacol Pharm; 1983; 35(6):467-72. PubMed ID: 6234517
[TBL] [Abstract][Full Text] [Related]
6. Chronic L-dopa treatment of rats and mice does not change the sensitivity of post-synaptic dopamine receptors.
Jackson DM; Jenkins OF; Malor R; Christie MJ; Gregory P
Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):271-4. PubMed ID: 6686648
[TBL] [Abstract][Full Text] [Related]
7. Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on the supersensitivity of dopamine receptors in brain induced by chronic administration of haloperidol to rats.
Bhargava HN
Neuropharmacology; 1984 Apr; 23(4):439-44. PubMed ID: 6145116
[TBL] [Abstract][Full Text] [Related]
8. The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice.
Dolphin AC; Jenner P; Marsden CD
Pharmacol Biochem Behav; 1976 Jun; 4(6):661-70. PubMed ID: 981283
[TBL] [Abstract][Full Text] [Related]
9. Chronic L-DOPA treatment of mice: a behavioural and biochemical study.
Bailey R; Crisp E; Jackson DM; Jenkins O
J Neural Transm; 1981; 50(2-4):209-24. PubMed ID: 6787171
[TBL] [Abstract][Full Text] [Related]
10. The effects on central dopamine function of chronic L-dopa (methyl ester hydrochloride) treatment of mice.
Tabar J; Hashizume M; Cook CJ; Beart PM; Jackson DM
Pharmacol Biochem Behav; 1989 May; 33(1):139-46. PubMed ID: 2789405
[TBL] [Abstract][Full Text] [Related]
11. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
[TBL] [Abstract][Full Text] [Related]
12. The demonstration of a change in responsiveness of mice to physostigmine and atropine after withdrawal from long-term haloperidol pretreatment.
Dunstan R; Jackson DM
J Neural Transm; 1977; 40(3):181-9. PubMed ID: 874470
[TBL] [Abstract][Full Text] [Related]
13. Hypothesis: bromocriptine lacks intrinsic dopamine receptor stimulating properties.
Jackson DM; Jenkins OF
J Neural Transm; 1985; 62(3-4):219-30. PubMed ID: 3897455
[TBL] [Abstract][Full Text] [Related]
14. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
15. The effect of chronic L-dopa administration on supersensitive pre- and postsynaptic dopaminergic receptors in rat brain.
Reches A; Wagner HR; Jiang D; Jackson V; Fahn S
Life Sci; 1982 Jul; 31(1):37-44. PubMed ID: 7109853
[TBL] [Abstract][Full Text] [Related]
16. Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity.
Creese I; Burt DR; Snyder SH
Science; 1977 Aug; 197(4303):596-8. PubMed ID: 877576
[TBL] [Abstract][Full Text] [Related]
17. Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol.
Seeger TF; Thal L; Gardner EL
Psychopharmacology (Berl); 1982; 76(2):182-7. PubMed ID: 6805029
[TBL] [Abstract][Full Text] [Related]
18. Different roles of D-1 and D-2 dopamine receptors involved in locomotor activity of supersensitive mice.
Rubinstein M; Gershanik O; Stefano FJ
Eur J Pharmacol; 1988 Apr; 148(3):419-26. PubMed ID: 2968273
[TBL] [Abstract][Full Text] [Related]
19. Central effects of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in mice.
Maj J; Rogóz Z; Skuza G
Pol J Pharmacol; 1993; 45(4):349-60. PubMed ID: 7906989
[TBL] [Abstract][Full Text] [Related]
20. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
Zharkovskiĭ AM; Matvienko OA; Nurk AM
Biull Eksp Biol Med; 1984 Oct; 98(10):444-6. PubMed ID: 6541951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
